EUVIMEDEUVIMED entdecken
Open Access

Intronic Germline DICER1 Variants in Patients With Sertoli-Leydig Cell Tumor

Claudette R Fraire iD, Paige R Mallinger, Jessica N Hatton iD, Jung Kim iD, David S Dickens iD, Peter A Argenta, Samuel Milanovich, Taylor Hartshorne iD, David J Carey, Jeremy S Haley, Gretchen Urban, Jeon Lee iD und 4 weitere

JCO Precision Oncology · 2023-09 · (7)

DOI: 10.1200/po.23.00189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Precision Oncology, 2023-09. Verfasst von Claudette R Fraire und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX. Hauptthemen laut MEDLINE: Sertoli-Leydig Cell Tumor, Ovarian Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sequencing introns in cancer predisposition genes detects novel loss-of-function variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sertoli-Leydig Cell TumorOvarian NeoplasmsMaleFemaleHumansIntronsGerm-Line MutationMutationRibonuclease IIIDEAD-box RNA Helicases

Substanzen

Ribonuclease IIIDICER1 protein, humanDEAD-box RNA Helicases

Autor:innen und Institutionen

  • Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX.
  • International Pleuropulmonary Blastoma (PPB)/DICER1 Registry, Children's Minnesota, Minneapolis, MN.
  • International Ovarian and Testicular Stromal Tumor (OTST) Registry, Children's Minnesota, Minneapolis, MN.
  • Cancer and Blood Disorders, Children's Minnesota, Minneapolis, MN.
  • Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD.
  • Department of Pediatrics, University of Iowa, Iowa City, IA.

ORCID-Profile: Claudette R Fraire, Jessica N Hatton, Jung Kim, David S Dickens, Taylor Hartshorne, Jeon Lee, D Ashley Hill, Douglas R Stewart, Kris Ann P Schultz, Kenneth S Chen

Förderung

  • NCI NIH HHS

Zitieren

APA

Fraire, C. R., Mallinger, P. R., Hatton, J. N., Kim, J., Dickens, D. S., Argenta, P. A., Milanovich, S., Hartshorne, T., Carey, D. J., Haley, J. S., Urban, G., Lee, J., Hill, D. A., Stewart, D. R., Schultz, K. A. P., & Chen, K. S. (2023). Intronic Germline DICER1 Variants in Patients With Sertoli-Leydig Cell Tumor. JCO Precision Oncology. https://doi.org/10.1200/po.23.00189

Vancouver

Fraire CR, Mallinger PR, Hatton JN, Kim J, Dickens DS, Argenta PA, et al. Intronic Germline DICER1 Variants in Patients With Sertoli-Leydig Cell Tumor. JCO Precision Oncology. 2023. doi:10.1200/po.23.00189

BibTeX
@article{Fraire2023,
  author = {Fraire, Claudette R and Mallinger, Paige R and Hatton, Jessica N and Kim, Jung and Dickens, David S and Argenta, Peter A and Milanovich, Samuel and Hartshorne, Taylor and Carey, David J and Haley, Jeremy S and Urban, Gretchen and Lee, Jeon and Hill, D Ashley and Stewart, Douglas R and Schultz, Kris Ann P and Chen, Kenneth S},
  title = {Intronic Germline DICER1 Variants in Patients With Sertoli-Leydig Cell Tumor},
  journal = {JCO Precision Oncology},
  year = {2023},
  number = {7},
  doi = {10.1200/po.23.00189}
}
Kostenlos starten →